CUSIP: 29668H104
Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
10,969,060
-
Share change
-
-1,799
-
Total reported value
-
$33,137,000
-
Price per share
-
$3.10
-
Number of holders
-
9
-
Value change
-
-$4,498
-
Number of sells
-
1
Quarterly Holders Quick Answers
What is CUSIP 29668H104?
CUSIP 29668H104 identifies 29668H104 - ESSA PHARMA INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2017
-
Previous quarter:
Q4 2016
Recent filing periods for CUSIP 29668H104:
Institutional Holders of ESSA PHARMA INC - COM as of Q1 2017
As of 31 Mar 2017,
ESSA PHARMA INC - COM was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,969,060 shares.
The largest 9 holders included
EVENTIDE ASSET MANAGEMENT, LLC, DEERFIELD MANAGEMENT CO, Clarus Ventures, LLC, Omega Fund Management, LLC, AWM Investment Company, Inc., ACUTA CAPITAL PARTNERS, LLC, ROYAL BANK OF CANADA, BANK OF MONTREAL /CAN/, and Tower Research Capital LLC (TRC).
This page lists
9
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.